Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children

Autor: Arkendu Chatterjee, Sabyasachi Bandyopadhyay, Samir Kumar Bandyopadhyay

Publikováno v: Journal of Ophthalmic & Vision Research, Vol 14, Pp 412-418 (2019)

Purpose: To evaluate the efficacy, safety, and steroid-sparing effect of topical cyclosporine A (Cs A) 0.05% in patients with moderate to severe steroid dependent vernal keratoconjunctivitis (VKC). Methods: A prospective, comparative, placebo control

Externí odkaz: https://doaj.org/article/2545141aa6564fb6984070bfdad0cbfa

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study

Autor: Manal F. Abdelmalek, Arun J. Sanyal, Atsushi Nakajima, Brent A. Neuschwander-Tetri, Zachary D. Goodman, Eric J. Lawitz, Stephen A. Harrison, Ira M. Jacobson, Kento Imajo, Nadege Gunn, Dina Halegoua-DeMarzio, Takemi Akahane, Bradly Boone, Masayuki Yamaguchi, Arkendu Chatterjee, Giridhar S. Tirucherai, Diane E. Shevell, Shuyan Du, Edgar D. Charles, Rohit Loomba

Publikováno v: Clinical Gastroenterology and Hepatology.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5d48865c48c1b581b38d9670061b22b8
https://doi.org/10.1016/j.cgh.2023.04.012

Pembrolizumab for previously treated advanced anal squamous cell carcinoma:results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study

Autor: Aurelien Marabelle, Philippe A Cassier, Marwan Fakih, Steven Kao, Dorte Nielsen, Antoine Italiano, Tormod Kyrre Guren, Marloes G J van Dongen, Kristen Spencer, Giovanni Mendonca Bariani, Paolo A Ascierto, Armando Santoro, Manisha Shah, Jamil Asselah, Syma Iqbal, Shunji Takahashi, Sarina A Piha-Paul, Patrick A Ott, Arkendu Chatterjee, Fan Jin, Kevin Norwood, Jean-Pierre Delord

Publikováno v: Marabelle, A, Cassier, P A, Fakih, M, Kao, S, Nielsen, D, Italiano, A, Guren, T K, van Dongen, M G J, Spencer, K, Bariani, G M, Ascierto, P A, Santoro, A, Shah, M, Asselah, J, Iqbal, S, Takahashi, S, Piha-Paul, S A, Ott, P A, Chatterjee, A, Jin, F, Norwood, K & Delord, J P 2022, ' Pembrolizumab for previously treated advanced anal squamous cell carcinoma : results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study ', The Lancet Gastroenterology and Hepatology, vol. 7, no. 5, pp. 446-454 . https://doi.org/10.1016/S2468-1253(21)00382-4

Background: Outcomes in advanced anal squamous cell carcinoma are poor, with few treatment options and controlled clinical trials. We evaluated the efficacy and safety of pembrolizumab in patients with advanced anal squamous cell carcinoma (cohort A)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3240b04252e2b3ad51d90da2d3fca0d9
https://curis.ku.dk/ws/files/359087816/1_s2.0_S2468125321003824_am.pdf

Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study

Autor: F. Jin, Nobukazu Fujimoto, Steven Kao, David Planchard, Kozo Kuribayashi, Bo Gao, Ignacio Matos, Arkendu Chatterjee, Hedy L. Kindler, Kazuhiko Nakagawa, Timothy A. Yap, Kevin Norwood, Ronnie Shapira-Frommer, Luana Calabrò, Tormod Kyrre Guren

Summary Background Malignant pleural mesothelioma (MPM) has few treatment options. Pembrolizumab showed preliminary clinical benefit in programmed death ligand 1 (PD-L1)-positive MPM. We evaluated the efficacy and safety of pembrolizumab monotherapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13fca0cd0a293e9f40756252e08cd87d
https://hdl.handle.net/11392/2492734

Quantitative Structure-Activity Relationships (QSARs) Modeling of Anti-hypertensive Activity of Dichloroanilino Imidazoline Derivatives

Autor: Somenath Bhattacharya, Injamul Hoque, Arkendu Chatterjee

Publikováno v: American Journal of PharmTech Research. 8:161-178

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9aadbf8deb9ccbaaf2270aadc6417ac0
https://doi.org/10.46624/ajptr.2018.v8.i3.013